Change over period: —
NSE · ZOTA
Zota Health Care Ltd
-22.1% from the 52-week high · +27.9% above the low
Zota Health Care Ltd. engages in the manufacture, sale and export of pharmaceutical products. The company is headquartered in Surat, Gujarat. The company went IPO on 2017-05-10. The firm manufactures, markets, and exports pharmaceutical, ayurvedic, nutraceutical, and over the counter (OTC) products. The Company’s business model comprises three verticals, namely Domestic, Exports and Retail Pharmacy Chain (Davaindia). Its Marketing business vertical involves the direct distribution of generic drugs, OTC products, and other pharmaceutical products through the Company’s distribution network across India. The company has a portfolio of more than 3,000 products in various categories, such as generics, OTC products, allopathic, ayurvedic and others. In the Retail Pharmacy Chain business vertical, it operates a chain of pharmacy stores under the brand Davaindia. Its domestic products include AMLOTOZ AT Tab, APIXACEED 2.5 Tab, APIXACEED 5 Tab, ATRONA 10 Tab, ATRONA 20 Tab, ATRONA 40 Tab, ATRONA ASP 75 Cap, ATRONA ASP 150 Cap, ATRONA ASP 20/75 Cap, ATRONA FB Tab and others.
The short version. Zota Health Care Ltd reported revenue of ₹199 crore for Sep 2026, up 54.3% from a year earlier. Net profit was ₹-26 crore. Return on equity was -10.7% in Mar 2026. Promoter holding was 49.38% in Sep 2026, down 12.64 points over 8 quarters.
1 · The price
How has the stock traded?
Zota Health Care Ltd trades 22.1% below its 52-week high and 27.9% above its 52-week low.
2 · The business
Is it growing?
Sep 2026 revenue of ₹199 cr.
0.4 pts lower than a year earlier.
Revenue compounded at 56.7% over the same 3 years.
Reported results · ₹ crore
Revenue and profit
Show the numbers
Quarterly
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 199 | 174 | 163 | 143 | 129 | 104 | 97 | 72 |
| Net profit | -26 | -44 | -14 | -30 | -16 | -14 | -13 | -19 |
| Net margin % | -12.8 | -25.1 | -8.7 | -20.6 | -12.4 | -13.8 | -13.3 | -25.9 |
| EPS (₹) | -7.39 | -12.58 | -4.09 | -8.74 | -5.2 | -4.81 | -4.5 | -6.78 |
Annual
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|---|
| Revenue | 539 | 293 | 180 | 140 | 131 | 107 | 95 |
| Net profit | -74 | -56 | -14 | -6 | 9 | 0 | 3 |
| Net margin % | -13.7 | -19.3 | -7.9 | -4.1 | 6.8 | -0.2 | 2.9 |
| EPS (₹) | -21.35 | -19.7 | -5.55 | -2.29 | 3.54 | -0.09 | 1.12 |
3 · The quality
How well does it turn capital into profit?
Return on equity was -10.7% in Mar 2026; debt to equity is 0.04.
Profitability · 4 years
Returns and margins
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | |
|---|---|---|---|---|
| Return on equity % | -10.7 | -25.2 | -16.0 | -7.2 |
| Return on capital % | -7.0 | -13.8 | -7.4 | -1.8 |
| EBITDA margin % | 3.7 | -1.2 | 4.8 | 6.9 |
| Net margin % | -13.5 | -19.1 | -7.9 | -4.1 |
Compound growth
Revenue vs profit
| 3 years | 5 years | |
|---|---|---|
| Revenue CAGR | 56.7% | 38.3% |
| Profit CAGR | 134.0% | 223.4% |
4 · The owners
Who holds it, and are they adding?
Down 12.64 pts over 8 quarters.
Up 6.68 pts over 8 quarters.
Up 6.27 pts over 8 quarters.
+2 versus the previous month.
Shareholding pattern (%)
Quarter by quarter
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Change | |
|---|---|---|---|---|---|---|---|---|---|
| Promoter | 62.02 | 59.72 | 57.42 | 55.81 | 50.64 | 49.38 | 49.38 | 49.38 | -12.64 |
| FII | 0.24 | 0.87 | 3.82 | 3.49 | 8.09 | 8.21 | 7.92 | 6.92 | +6.68 |
| DII | 1.03 | 3.08 | 4.25 | 4.95 | 7.22 | 6.4 | 6.75 | 7.3 | +6.27 |
| Public | 36.71 | 36.33 | 34.52 | 35.75 | 34.06 | 36.0 | 35.96 | 36.4 | -0.31 |
Mutual fund holdings · Oct 2026
2 schemes hold this stock
0 the month before.
- WhiteOak Capital Special Opportunities Fund0.54% of NAV
- WhiteOak Capital Pharma and Healthcare Fund0.4% of NAV
5 · The model view
What does our factor model say?
Factor scores, model flags and screen results for Zota Health Care Ltd are part of the Wright portfolio review.
Run your free portfolio reviewWatchouts
What to review
Model flags are shown inside the portfolio review, alongside your other holdings.
Related stocks
Other Pharmaceuticals & Biotechnology stocks
Quick answers
Common questions about Zota Health Care Ltd
What is the Zota Health Care Ltd share price?
Zota Health Care Ltd (ZOTA) last closed at ₹1,306.00, down 0.65% on the day. Its 52-week range is ₹1,028.10 to ₹1,687.00.
What is the market cap of Zota Health Care Ltd?
Zota Health Care Ltd has a market capitalisation of about ₹4,552 crore.
How are Zota Health Care Ltd's latest results?
Zota Health Care Ltd reported revenue of ₹199 crore for Sep 2026, up 54.3% from a year earlier. Net profit was ₹-26 crore. Return on equity was -10.7% in Mar 2026. Promoter holding was 49.38% in Sep 2026, down 12.64 points over 8 quarters.
Who owns Zota Health Care Ltd?
As of Sep 2026, shareholding was: Promoter 49.38%, FII 6.92%, DII 7.3%, Public 36.4%.
How many mutual funds hold Zota Health Care Ltd?
2 mutual fund schemes held Zota Health Care Ltd in October 2026. That compares with 0 the month before.
Corporate actions
Recent dividends, bonuses and splits
- 22 Sep 2025 · Dividend - Rs. 1
- 20 Sep 2024 · Dividend - Rs. 1
- 22 Sep 2023 · Dividend - Rs. 1
- 19 Sep 2022 · Dividend - Rs. 1.5
- 22 Sep 2021 · Dividend - Rs. 1
- 17 Sep 2020 · Dividend - Rs. 1
Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.
Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.